1. Home
  2. MTEX vs PULM Comparison

MTEX vs PULM Comparison

Compare MTEX & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • PULM
  • Stock Information
  • Founded
  • MTEX 1993
  • PULM 2003
  • Country
  • MTEX United States
  • PULM United States
  • Employees
  • MTEX N/A
  • PULM N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • PULM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEX Health Care
  • PULM Health Care
  • Exchange
  • MTEX Nasdaq
  • PULM Nasdaq
  • Market Cap
  • MTEX 23.0M
  • PULM 26.8M
  • IPO Year
  • MTEX 1999
  • PULM N/A
  • Fundamental
  • Price
  • MTEX $12.07
  • PULM $6.17
  • Analyst Decision
  • MTEX
  • PULM
  • Analyst Count
  • MTEX 0
  • PULM 0
  • Target Price
  • MTEX N/A
  • PULM N/A
  • AVG Volume (30 Days)
  • MTEX 6.9K
  • PULM 150.6K
  • Earning Date
  • MTEX 11-12-2024
  • PULM 11-08-2024
  • Dividend Yield
  • MTEX N/A
  • PULM N/A
  • EPS Growth
  • MTEX N/A
  • PULM N/A
  • EPS
  • MTEX N/A
  • PULM N/A
  • Revenue
  • MTEX $121,552,000.00
  • PULM $10,005,000.00
  • Revenue This Year
  • MTEX N/A
  • PULM N/A
  • Revenue Next Year
  • MTEX N/A
  • PULM $1.00
  • P/E Ratio
  • MTEX N/A
  • PULM N/A
  • Revenue Growth
  • MTEX N/A
  • PULM 47.05
  • 52 Week Low
  • MTEX $6.75
  • PULM $1.55
  • 52 Week High
  • MTEX $13.00
  • PULM $8.44
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 66.59
  • PULM 62.29
  • Support Level
  • MTEX $10.08
  • PULM $5.65
  • Resistance Level
  • MTEX $12.40
  • PULM $6.17
  • Average True Range (ATR)
  • MTEX 0.84
  • PULM 0.57
  • MACD
  • MTEX 0.18
  • PULM -0.14
  • Stochastic Oscillator
  • MTEX 85.71
  • PULM 31.93

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

Share on Social Networks: